Conditioned room air delivered transnasally is safe, effective and tolerable for treatment of acute migraine, according to findings from a new study led by a Cleveland Clinic researcher.
The results provide the first proof-of-concept for the Mi-Helper, a noninvasive device by My-Helper Inc., which requires no drugs or chemicals. They were presented at the American Academy of Neurology Annual Meeting in San Diego, California.